Publications by authors named "Jacob Evan"

Claim this Profile
C
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials.
Jimin Ren, Richard B Dewey, Austin Rynders, Jacob Evan, Jeremy Evan

J Nanobiotechnology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials.
Jimin Ren, Richard B Dewey, Austin Rynders, Jacob Evan, Jeremy Evan

J Nanobiotechnology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension.
Steve Vucic, Parvathi Menon, William Huynh, Colin Mahoney, Karen S Ho, Jacob Evan, Jeremy Evan

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis